Targeted Therapy in Head and Neck Cancer

被引：3
|
作者：
Ward, Brent B. [1 ]
机构：
[1] Univ Michigan, Ann Arbor, MI 48109 USA
来源：
ORAL AND MAXILLOFACIAL SURGERY CLINICS OF NORTH AMERICA | 2013年 / 25卷 / 01期
关键词：
Cancer; Nanotechnology; Chemotherapy; Radiation; Targeted therapy; SQUAMOUS-CELL CARCINOMA; TRANSORAL ROBOTIC SURGERY; LYMPH-NODE BIOPSY; SURGICAL MARGINS; PLUS CETUXIMAB; SIGNALING NETWORK; ANIMAL-MODEL; ORAL-CANCER; DISSECTION; CHEMOTHERAPY;
D O I：
10.1016/j.coms.2012.11.006
中图分类号：
R78 [口腔科学];
学科分类号：
1003 ;
摘要：
The desire to target therapies to specific cancers while leaving the host unharmed remains an ongoing quest for scientists, surgeons, radiation oncologists, and medical oncologists. In recent years, great scientific progress has been made in targeted therapies. Although many modalities remain in preclinical validation, some advances affect patient care today. This article summarizes the concepts of targeting and explores current examples of successful targeting and emerging targeting technologies in head and neck oncology.
引用
收藏
页码：83 / +
页数：12
相关论文
共 50 条
  • [21] Adjuvant therapy in head and neck cancer. State of the art
    Schwenzer-Zimmerer, K.
    Kansy, K.
    Zeilhofer, H-F
    Zippelius, A.
    Zimmermann, F.
    MKG-CHIRURG, 2010, 3 (01): : 25 - 29
  • [22] Oral metronomic therapy in head and neck cancer
    Pramanik, Raja
    Sharma, Atul
    Kumar, Akash
    LANCET GLOBAL HEALTH, 2021, 9 (01): : E19 - E19
  • [23] The immunogenic radiation and new players in immunotherapy and targeted therapy for head and neck cancer
    Sharon, Shay
    Daher-Ghanem, Narmeen
    Zaid, Deema
    Gough, Michael J.
    Kravchenko-Balasha, Nataly
    FRONTIERS IN ORAL HEALTH, 2023, 4
  • [24] Clinical implication of genetic intratumor heterogeneity for targeted therapy in head and neck cancer
    Gram, Signe Buhl
    Alosi, Daniela
    Bagger, Frederik Otzen
    Ostrup, Olga
    von Buchwald, Christian
    Friborg, Jeppe
    Wessel, Irene
    Vogelius, Ivan Richter
    Rohrberg, Kristoffer
    Rasmussen, Jacob Hoygaard
    ACTA ONCOLOGICA, 2023, 62 (12) : 1831 - 1839
  • [25] Epidermal Growth Factor Receptor-Targeted Therapy for Head and Neck Cancer
    Trivedi, Sumita
    Ferris, Robert L.
    OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA, 2021, 54 (04) : 743 - 749
  • [26] Integration of molecular targeted therapy with radiation in head and neck cancer
    Du, Yu
    Peyser, Noah D.
    Grandis, Jennifer R.
    PHARMACOLOGY & THERAPEUTICS, 2014, 142 (01) : 88 - 98
  • [27] Molecular targeted therapies in head and neck cancer's treatment
    Even, C.
    Le Tourneau, C.
    ONCOLOGIE, 2015, 17 (5-6) : 239 - 244
  • [28] A population-based study of therapy and survival for patients with head and neck cancer treated in the community
    Ullmann, Claudio Dansky
    Harlan, Linda C.
    Shavers, Vickie L.
    Stevens, Jennifer L.
    CANCER, 2012, 118 (18) : 4452 - 4461
  • [29] Reirradiation of Recurrent and Second Primary Head and Neck Cancer With Proton Therapy
    McDonald, Mark W.
    Zolali-Meybodi, Omid
    Lehnert, Stephen J.
    Estabrook, Neil C.
    Liu, Yuan
    Cohen-Gadol, Aaron A.
    Moore, Michael G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (04): : 808 - 819
  • [30] CHEMOTHERAPY AND TARGETED THERAPY IN ADENOID CYSTIC CARCINOMA OF THE HEAD AND NECK: A REVIEW
    Papaspyrou, Giorgos
    Hoch, Stephan
    Rinaldo, Alessandra
    Rodrigo, Juan P.
    Takes, Robert P.
    van Herpen, Carla
    Werner, Jochen A.
    Ferlito, Alfio
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2011, 33 (06): : 905 - 911
12345